News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Melissa Fassbender
- Last updated on
Previously the chief commercial officer at Science Exchange, Bracket has added Christopher Crucitti to its global executive team as the new chief commercial officer.
“My priority and focus at Bracket will be to leverage the strong existing infrastructure, operational and scientific talent and technology product suite to align a valuable and differentiating portfolio of solutions that meet our customers’, including sponsors and CRO partners, current and future needs,” Crucitti told us.
“By doing so, I continue to be excited by the growth opportunity in our current and target solution categories; most notably neuroscience, clinical supply chain and mHealth/eCOA.”
Crucitti was also previously executive vice president, global business development at Worldwide Clinical Trials, Inc. He also held senior roles at inVentiv Health Clinical and i3 Research.